Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

Verma, N; Dua, K; Sarin, A

Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases

Verma, N Dua, K

Sarin, A

Permalink

Publisher:: Springer
Publication Type:: Chapter
Citation:: Medicinal Plants for Lung Diseases, 2021, pp. 557-582
Issue Date:: 2021-07-31

Closed Access

	Filename	Description	Size
	978-981-33-6850-7_24.pdf	Published version	652.51 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Verma, N
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.contributor.author	Sarin, A
dc.date.accessioned	2023-01-10T22:18:43Z
dc.date.available	2023-01-10T22:18:43Z
dc.date.issued	2021-07-31
dc.identifier.citation	Medicinal Plants for Lung Diseases, 2021, pp. 557-582
dc.identifier.isbn	978-981-33-6849-1
dc.identifier.uri	http://hdl.handle.net/10453/164823
dc.description.abstract	Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant anti-microbials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks
dc.format.extent	27
dc.language	en
dc.publisher	Springer
dc.relation.ispartof	Medicinal Plants for Lung Diseases
dc.relation.isbasedon	10.1007/978-981-33-6850-7_24
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Medicinal Plant-Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases
dc.type	Chapter
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
utslib.copyright.status	closed_access	*
pubs.consider-herdc	false
dc.date.updated	2023-01-10T22:18:38Z
pubs.place-of-publication	Switzerland
pubs.publication-status	Published
dc.location	Switzerland

Abstract:

Lung disease represents a significant medical problem worldwide. They are usually treated by different synthetic drugs. Yet, incessant high-portion of oral and injectable medications may prompt extreme side effects and at this crossroad, there is a requirement of inhaled formulations that encourage successful medication to the pulmonary routes with no adverse effects. Chemicals isolated form plants, i.e. Common phytoconstituents or phytoalexin (for example, plant anti-microbials) have indicated a remarkable treatment cluster with least adverse effects and incredible ability to treat intrapulmonary and extrapulmonary illnesses contrasted with synthetic medications. In addition, the advancement and integration of various sciences, for example, nanoscience, polymer sciences, material science, and molecule designing along with particles shape and size analysis permits further improvement of the treatment capacity and productivity. This chapter highlights the plant-based advanced drug delivery system for the treatment of chronic lung diseases. Moreover, it also facilitates the scientist with some fundamental foundation data to phytochemical profile, plan prerequisites and medication conveyance frameworks

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/164823